Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125641761 | 12564176 | 1 | I | 20160705 | 20160718 | 20160718 | EXP | CA-HQ SPECIALTY-CA-2016INT000535 | INTERCHEM | 61.00 | YR | F | Y | 0.00000 | 20160715 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125641761 | 12564176 | 1 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | 3.5714 MG (25 MG, 1 IN 1 W) | 201749 | 25 | MG | |||||||||
| 125641761 | 12564176 | 2 | SS | FOLIC ACID. | FOLIC ACID | 1 | UNK | 0 | |||||||||||
| 125641761 | 12564176 | 3 | SS | ARAVA | LEFLUNOMIDE | 1 | Oral | 20 MG (20 MG, 1 IN 1 D) | N | 0 | 20 | MG | |||||||
| 125641761 | 12564176 | 4 | SS | PLAQUENIL /00072602/ | HYDROXYCHLOROQUINE DIPHOSPHATE | 1 | EVERDAY BESIDES SUNDAY (200 MG, 1 IN 1 D) | 0 | 200 | MG | |||||||||
| 125641761 | 12564176 | 5 | SS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | 14.2857 MG (200 MG, 1 IN 2 W) | N | 0 | 200 | MG | ||||||||
| 125641761 | 12564176 | 6 | SS | HUMIRA | ADALIMUMAB | 1 | UNK | N | 0 | ||||||||||
| 125641761 | 12564176 | 7 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | 10.0357 MG (281 MG,1 IN 4 W) | N | 0 | 281 | MG | |||||||
| 125641761 | 12564176 | 8 | SS | ACTEMRA | TOCILIZUMAB | 1 | Subcutaneous | 162 MG,1 W | N | 0 | 162 | MG | |||||||
| 125641761 | 12564176 | 9 | SS | PREDNISONE. | PREDNISONE | 1 | ALTERNATE DAY (EVERY SECOND FOR NEXT 2 WEEKS) (2 DOSAGE FORM) | 0 | 2 | DF |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125641761 | 12564176 | 1 | Rheumatoid arthritis |
| 125641761 | 12564176 | 2 | Product used for unknown indication |
| 125641761 | 12564176 | 3 | Rheumatoid arthritis |
| 125641761 | 12564176 | 4 | Rheumatoid arthritis |
| 125641761 | 12564176 | 5 | Rheumatoid arthritis |
| 125641761 | 12564176 | 6 | Rheumatoid arthritis |
| 125641761 | 12564176 | 7 | Rheumatoid arthritis |
| 125641761 | 12564176 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125641761 | 12564176 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125641761 | 12564176 | Drug dose omission | |
| 125641761 | 12564176 | Drug ineffective | |
| 125641761 | 12564176 | Fatigue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125641761 | 12564176 | 1 | 201201 | 0 | ||
| 125641761 | 12564176 | 3 | 201209 | 201310 | 0 | |
| 125641761 | 12564176 | 4 | 201201 | 0 | ||
| 125641761 | 12564176 | 5 | 201310 | 201312 | 0 | |
| 125641761 | 12564176 | 7 | 201403 | 201410 | 0 | |
| 125641761 | 12564176 | 8 | 201410 | 201506 | 0 |